Global Lipid Profile Market, By Type (Total Cholesterol, LDL (Low-Density Lipoprotein), HDL (High-Density Lipoprotein), Triglycerides), Indication (High Blood Pressure, Genetic Disease, Diabetes, Obesity, Others), Technology (PCR Based, ELISA, Others), Distribution Channel (Online, Retail, Direct Tender), Medication (Statins, Niacin, Fibrates, Zetia, Bile Acid Sequestrants), End User (Clinics, Hospitals, Ambulatory Centers, Homecare, Diagnostic Centers) – Industry Trends and Forecast to 2029.
Lipid Profile Market Analysis and Size
The lipid profile market is expected to grow in the forecast period of 2022-2029. The healthcare sector is boosting the market growth of the global lipid profile market due to growing technological innovations together with biosensors, lab-on-a-chip, smartphone apps, and other wearable devices, contributing a major share of inpatient- point-of-care technologies. An increase in the geriatric population, increasing frequency of obesity, cardiovascular, diabetic diseases, and motivating healthcare awareness are further boosting the market growth.
Data Bridge Market Research analyses that the lipid profile market which was USD 670 million in 2021, would rocket up to USD 1067.88 million by 2029, and is expected to undergo a CAGR of 6.00% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Lipid Profile Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Type (Total Cholesterol, LDL (Low-Density Lipoprotein), HDL (High-Density Lipoprotein), Triglycerides), Indication (High Blood Pressure, Genetic Disease, Diabetes, Obesity, Others), Technology (PCR Based, ELISA, Others), Distribution Channel (Online, Retail, Direct Tender), Medication (Statins, Niacin, Fibrates, Zetia, Bile Acid Sequestrants), End User (Clinics, Hospitals, Ambulatory Centers, Homecare, Diagnostic Centers)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Abbott (U.S.), Akers Biosciences, Inc. (U.S.), Beckman Coulter, Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Eurofins Scientific (Luxembourg), Boston Heart Diagnostics Corporation (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Home Access Health (U.S.), Laboratory Corporation of America Holdings (U.S.), PRIMA Lab SA (Switzerland), Quest Diagnostics Incorporated (U.S.), Randox Laboratories Ltd. (U.K.), Sekisui Diagnostics (U.S.), Siemens (Germany), Merck KGaA (Germany)
|
|
Market Opportunities
|
|
Market Definition
A lipid profile is a collection of blood tests used to measure the blood's triglyceride and cholesterol levels. Additionally, these cause unhealthful weight gain. Lipids are chemical molecules generally referred to as fatty acid derivatives and other compounds made by plants and animals. The industry is anticipated to develop between 2022-2029 as a result of rising health awareness among consumers and rising demand for lipids as nutritional supplements. Furthermore, lipids are crucial in the prevention of chronic illnesses such arthritis, asthma, cancer, cystic fibrosis, and diabetes, which is anticipated to further expand the market.
Global Lipid Profile Market Dynamics
Drivers
- Rise in chronic diseases
In the forecast period of 2022–2029, factors such as the rising prevalence of geriatric and obese populations worldwide, rising cardiovascular disease and diabetes cases, rising funding levels for the development of cutting-edge and technologically innovative testing products, and the adoption of non-invasive procedures are likely to boost the growth of the lipid profile market.
- Use of POC diagnostics
On the other hand, a better distribution network and the use of POC diagnostics will open up more chances and fuel the expansion of the lipid profile market over the forecast period.
Opportunities
- Prevalence of chronic diseases
The market's growth is fuelled by prevalence of chronic diseases, changing food habits contribute to the intake of supplements and energy providing food, increasing industrialization, and growing health consciousness and awareness about the health benefits of lipid. These will provide beneficial opportunities for the market growth.
Restraints/Challenges
- Lack of healthcare infrastructure
On the other hand, lack of awareness among the people regarding new treatment method in developing economies will restrains the market growth. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the market.
This lipid profile market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the lipid profile market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Lipid Profile Market
The favourable effects on health, lipid-based supplements have become increasingly popular as a result of the ongoing COVID-19 pandemic. In an effort to fulfil the rising demand for the drug, Moderna Inc., a pharmaceutical firm based in the United States, has extended a contract with Corden Pharma to acquire significant quantities of the lipids required to make its experimental COVID-19 vaccine. Novel lipids have been emerging more often over the past ten years, and since they have such great potential for use in nutrition and medicine, it is anticipated that they will have a positive impact on the market in the years to come.
Global Lipid Profile Market Scope
The lipid profile market is segmented on the basis of type, indication, technology, distribution channel, medication and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Type
- Total Cholesterol
- LDL (Low-Density Lipoprotein)
- HDL (High-Density Lipoprotein)
- Triglycerides
Indication
- High Blood Pressure
- Genetic Disease
- Diabetes
- Obesity
- Others
Technology
- PCR Based
- ELISA
- Others
Distribution Channel
- Online
- Retail
- Direct Tender
Medication
- Statins
- Niacin
- Fibrates
- Zetia
- Bile Acid Sequestrants
End User
- Clinics
- Hospitals
- Ambulatory Centers
- Homecare
- Diagnostic Centers
Lipid Profile Market Regional Analysis/Insights
The lipid profile market is analysed and market size insights and trends are provided by country, type, indication, technology, distribution channel, medication and end user as referenced above.
The countries covered in the lipid profile market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the lipid profile market due to the adoption of advanced technology as well as rising geriatric and obese population.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2022 to 2029 due to the growing number of aging population along with changing lifestyle of the people.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The lipid profile market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for lipid profile market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the lipid profile market. The data is available for historic period 2010-2020.
Competitive Landscape and Lipid Profile Market Share Analysis
The lipid profile market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to lipid profile market.
Some of the major players operating in the lipid profile market are:
- Abbott (U.S.)
- Akers Biosciences, Inc. (U.S.)
- Beckman Coulter, Inc. (U.S.)
- Bio-Rad Laboratories, Inc. (U.S.)
- Eurofins Scientific (Luxembourg)
- Boston Heart Diagnostics Corporation (U.S.)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Home Access Health (U.S.)
- Laboratory Corporation of America Holdings (U.S.)
- PRIMA Lab SA (Switzerland)
- Quest Diagnostics Incorporated (U.S.)
- Randox Laboratories Ltd. (U.K.)
- Sekisui Diagnostics (U.S.)
- Siemens (Germany)
- Merck KGaA (Germany)
SKU-